| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| acetylcholine chloride | Solution, powder for irrigation | 10 mg/mL | Current | Unavailable | Manufacturing | 19/07/2024 |
| escitalopram oxalate | Tablet, film coated | 25.56 mg | Current | Limited Availability | Manufacturing | 19/07/2024 |
| insulin | Injection, solution | 100 IU/mL | Current | Limited Availability | Manufacturing | 19/07/2024 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Current | Limited Availability | Manufacturing | 19/07/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 21.75 mg | Anticipated | Available | Manufacturing | 19/07/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 19/07/2024 |
| oxycodone hydrochloride | Capsule, hard | 10 mg | Current | Unavailable | Commercial Changes / Commercial viability | 19/07/2024 |
| bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate | Injection, solution | 2.64 mg/mL~4.5 microgram/mL | Anticipated | Available | Manufacturing | 19/07/2024 |
| tamsulosin hydrochloride~dutasteride | Capsule, modified release | 400 microgram~500 microgram | Current | Limited Availability | Manufacturing | 19/07/2024 |
| ketorolac trometamol | Injection, solution | 30 mg/mL | Anticipated | Available | Manufacturing | 19/07/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 52.45 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 19/07/2024 |
| dexamethasone~framycetin sulfate~gramicidin | Ear Drops | .5 mg/mL~5 mg/mL~.05 mg/mL | Current | Unavailable | Manufacturing | 19/07/2024 |
| mianserin hydrochloride | Tablet, film coated | 20 mg | Anticipated | Available | Manufacturing | 19/07/2024 |
| pamidronate disodium | Injection, concentrated | 3 mg | Current | Unavailable | Manufacturing | 19/07/2024 |
| norethisterone | Tablet, uncoated | 350 microgram | Anticipated | Available | Manufacturing | 18/07/2024 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| sodium oxidronate | Injection, powder for | 3.15 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Current | Limited Availability | Manufacturing | 18/07/2024 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Resolved | Available | Manufacturing | 18/07/2024 |
| oseltamivir phosphate | Oral Liquid, powder for | 7.88 mg/mL | Current | Emergency Supply Only | Unexpected increase in consumer demand | 18/07/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 43.5 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 18/07/2024 |
| tadalafil | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 18/07/2024 |
| latanoprost | Eye Drops, solution | 50 microgram/mL | Current | Unavailable | Unexpected increase in consumer demand | 18/07/2024 |
| cefepime hydrochloride monohydrate | Injection, powder for | 2378.5 mg | Anticipated | Available | Manufacturing | 18/07/2024 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.819 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| olmesartan medoxomil~amlodipine besilate | Tablet, film coated | 20 mg~6.935 mg | Resolved | Available | Manufacturing | 18/07/2024 |
| amiodarone hydrochloride | Tablet, uncoated | 100 mg | Resolved | Available | Manufacturing | 18/07/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 26.22 mg/mL | Current | Unavailable | Manufacturing | 18/07/2024 |
| dostarlimab | Injection, intravenous infusion | 500 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 18/07/2024 |
| captopril | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Resolved | Available | Manufacturing | 18/07/2024 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 18/07/2024 |
| phytomenadione | Injection, solution | 10 mg/mL | Current | Limited Availability | Product recall | 18/07/2024 |
| sodium oxidronate | Injection, powder for | 3.15 mg | Current | Unavailable | Manufacturing | 18/07/2024 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 17/07/2024 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~10.396 mg | Current | Unavailable | Manufacturing | 17/07/2024 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 17/07/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Unavailable | Unexpected increase in consumer demand | 17/07/2024 |
| evolocumab | Injection, solution | 420 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 17/07/2024 |
| dobutamine hydrochloride | Injection, solution | 14.01 mg/mL | Resolved | Available | Manufacturing | 17/07/2024 |
| minocycline hydrochloride dihydrate | Tablet, film coated | 54 mg | Current | Limited Availability | Manufacturing | 17/07/2024 |
| icodextrin~sodium chloride~sodium lactate~calcium chloride dihydrate~magnesium chloride hexahydrate | Solution, dialysis | 75 g/L~5.4 g/L~4.5 g/L~257 mg/L~51 mg/L | Current | Limited Availability | Manufacturing | 17/07/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Resolved | Available | Manufacturing | 17/07/2024 |
| sevelamer hydrochloride | Tablet, film coated | 800 mg | Current | Unavailable | Manufacturing | 16/07/2024 |
| olanzapine | Tablet, uncoated | 7.5 mg | Current | Unavailable | Manufacturing | 16/07/2024 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 16/07/2024 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Resolved | Available | Manufacturing | 16/07/2024 |
| ezetimibe | Tablet | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 16/07/2024 |
| pemetrexed disodium | Injection, powder for | 551.4 mg | Current | Unavailable | Manufacturing | 16/07/2024 |
| fluticasone propionate | Inhalation, pressurised | 125 microgram/actuation | Resolved | Available | Unexpected increase in consumer demand | 16/07/2024 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/07/2024 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 16/07/2024 |
| azithromycin dihydrate | Tablet, film coated | 628.93 mg | Anticipated | Available | Manufacturing | 16/07/2024 |
| griseofulvin | Tablet, uncoated | 125 mg | Anticipated | Available | Manufacturing | 15/07/2024 |
| olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide | Tablet | 40 mg~6.944 mg~12.5 mg | Anticipated | Available | Manufacturing | 15/07/2024 |
| olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate | Tablet | 40 mg~25 mg~6.944 mg | Current | Limited Availability | Manufacturing | 15/07/2024 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~86.751 mg | Resolved | Available | Manufacturing | 15/07/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/07/2024 |
| pregabalin | Capsule, hard | 75 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 15/07/2024 |
| Rabies virus | Injection, powder for | 2.5 IU | Current | Emergency Supply Only | Manufacturing | 15/07/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg~.78 mg | Resolved | Available | Manufacturing | 15/07/2024 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 15/07/2024 |
| atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Current | Unavailable | Manufacturing | 15/07/2024 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 15/07/2024 |
| cefalexin monohydrate | Oral Liquid, powder for | 26.3 mg/mL | Resolved | Available | Manufacturing | 15/07/2024 |
| pravastatin sodium | Tablet, uncoated | 40 mg | Current | Limited Availability | Manufacturing | 15/07/2024 |
2024年7月22日